Qualified mPGES-1 inhibitors can circumvent the serious side effects of COX-2 inhibitors8,9, and targeted inhibition of mPGES-1 will play an important role in anti-inflammatory and tumour treatment33,.34 The gene discussed is PTGES; the disease is neoplasm.